Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts

Murine erythropoietic impairment induced by paclitaxel: Interactions of GATA-1 and erythroid Krüppel-like transcription factors, apoptotic related proteins and erythropoietin receptor

(2010) María Victoria Aguirre et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression

(2009) H Chen et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77

(2009) C. Ferlini et al.   CANCER RESEARCH

Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle – A new strategy against peritoneal dissemination of gastric cancer

(2008) Jun Yamada et al.   CANCER LETTERS

A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity

(2008) A. Banzato et al.   CLINICAL CANCER RESEARCH

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System

(2008) Stefan Holdenrieder et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

(2008) C. A. Maxwell et al.   JOURNAL OF CELL SCIENCE

Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†

(2008) Francesca Leonelli et al.   MOLECULES

The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer

(2008) Maurie Markman   ONCOLOGY

Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies

(2008) Maurie Markman   TRENDS IN PHARMACOLOGICAL SCIENCES

Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: A review of complications and completion rates

(2007) Lisa M. Landrum et al.   GYNECOLOGIC ONCOLOGY